Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Positive results from FLU-v vaccine challenge study (FLU-v 004), the second Phase IIb study of FLU-v, which has been developed by Imutex Limited, hVIVO’s 49% joint venture with the SEEK
Open Orphan (ORPH), the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine
Development of the World’s First Human Coronavirus Challenge Study Model
A recap of some of the video’s, podcast, interview, news stories Share Talk has covered this past week.
Initial study for the provision of a RSV human challenge study
Share Talk is, once again, very excited to have a stall at The Global Group UK Investor Show on 25th April this year.
Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine
It has been another interesting week across the small-cap markets, the FTSE AIM All-Share finally broke last year’s resistance (974), peaking this week at 978.05, before closing at 972.62. A